Study of Cell and Gene Therapy Research, Manufacturing, and Delivery

The Minnesota Rare Disease Advisory Council requests proposals for a feasibility study on Minnesota's current capacity for rare disease cell and gene therapy (CGT). The study should assess Minnesota's current CGT research, innovation, commercialization, and manufacturing ecosystem; identify strategic gaps and opportunities; evaluate investment models used by leading states; and develop recommendations for positioning Minnesota as a national leader in CGT development and commercialization. The cost proposal for this project should not exceed $40,000. \[Partial description. For the full description, log into the [Supplier Portal](https://guest.supplier.systems.state.mn.us/psc/fmssupap/SUPPLIER/ERP/c/NUI_FRAMEWORK.PT_LANDINGPAGE.GBL).\] **Event ID/Reference Number:** **UNKNOWN** If an Event ID/Reference number appears, this Solicitation Event is being conducted in the SWIFT system. All project documentation and vendor submissions should be completed at the State of Minnesota Supplier portal. Log in to the [Supplier Portal](https://guest.supplier.systems.state.mn.us/psc/fmssupap/SUPPLIER/ERP/c/NUI_FRAMEWORK.PT_LANDINGPAGE.GBL?&) to view this event. You will need to search for Event ID/Reference Number in the portal. If the Event ID/Reference Number shows "Unknown", then the full description can be found for this event in the State of Minnesota list of solicitations (select the appropriate page): [Goods and Services Solicitation Postings](https://osp.admin.mn.gov/GS-auto) or [Professional and Technical Solicitation Postings](https://osp.admin.mn.gov/PT-auto). You may locate it using the Ref. # that appears above.